Session Details

Plenary 2 - Cognitive Enhancing Drugs

Chairperson Henry Brodaty  
Chairperson Alistair Burns University of Manchester
The Case for Use of Cognitive Enhancers in the Treatment of Alzheimer's Disease - An Overview
  • Alistair Burns
    • Cognitive Enhancing Drugs: Critical Review of Drug Trial Methodology and Evidence
  • Deborah Ashby
    • New Drugs for Dementia - The Carer's Perspective
  • Jim Armstrong
    • Bying Drugs for Dementia - How Do We Assess Value for Money?
  • Suzanne Hill